Paragon Care Limited ( (AU:PGC) ) just unveiled an update.
Paragon Care Limited announced that Mr. John Walstab will transition from his executive role to a Non-Executive Director position effective 1 April 2025. Mr. Walstab, who founded Quantum Healthcare and played a key role in its merger with Paragon Care, will continue to contribute his expertise to the company’s board. This transition is part of Paragon Care’s strategy to integrate CH2 and ParagonCare, enhancing its growth prospects in the Asia-Pacific region.
More about Paragon Care Limited
Paragon Care Limited is an Australian-based company in the healthcare sector, providing durable medical equipment, medical devices, consumable medical products, and maintenance of technical medical equipment. It serves the health, aged care, and veterinary markets across Australia, New Zealand, and Asia, and distributes pharmaceuticals and complementary medicines in the Australian healthcare market.
YTD Price Performance: -18.62%
Average Trading Volume: 5,061
Technical Sentiment Consensus Rating: Hold
Current Market Cap: €403.3M
Learn more about PGC stock on TipRanks’ Stock Analysis page.